Turkish Pharmaceutical Market

Turkish Pharmaceutical Market (ex-factory prices)

The Turkish pharmaceutical market reached 47,9 billion Turkish Liras (TL) in 2020. During the same period unit sales reached 2,20 billion units.

Source: IQVIA, IEIS

Originator vs. Generic Drugs

Source: IQVIA,IEIS

Source: IQVIA,IEIS

Market Share of Originator vs Generic Drugs

  

Source: IQVIA,IEIS

Import-Local Products

Source: IQVIA, IEIS

Source: IQVIA, IEIS

Market Share - Import vs. Local

  

Source: IQVIA, IEIS

Pharmaceutical Consumption by Therapeutic Class

Pharmaceutical Consumption in Value Terms by Therapeutical Class

Oncology represented the largest proportion by value, accounting for 14,5% of the total market. 

Source: IQVIA, IEIS

Pharmaceutical Consumption in Volume Terms by Therapeutical Class

Cardiovascular drugs represented the largest proportion by volume, accounting for 10,5% of the total market.

Source: IQVIA, IEIS

Biotechnological Products

Biotechnological products constituted 18,2% of prescription products with 8,7 billion TL and 34,3 million units in 2020. The reference biotechnological pharmaceutical market grew by 22,5% to total 7,8 billion TL. Biosimilar drugs market increased by 48,3% and reached 907,1 million TL.
 

Source: IQVIA, IEIS

Source: IQVIA, IEIS

Foreign Trade

Pharmaceutical exports reached $1,8 billion in 2020.

Source:TurkStat, IEIS

Source:TurkStat, IEIS